Wednesday, September 13, 2023

Join the "Game Changers in Atopic Dermatitis" Session

Dear Dr. Renukaprasad A R,
Moderate-to-severe atopic dermatitis (AD) requires a systemic treatment approach. However, the adverse effects of traditional systemic treatments, including systemic corticosteroids, phototherapy, and immunosuppressants, necessitate safe and effective long-term therapy for refractory AD. In addition, biological therapies for AD are associated with the onset of paradoxical adverse effects, which is a challenging issue.
To learn more about the diagnosis and management of atopic dermatitis, join us for an exclusive session with Dr. Jaykar Thomas on "Game Changers in Atopic Dermatitis" TODAY, 6:00 PM IST onwards.
Session Highlights:
  • Recognizing the burden of moderate-severe atopic dermatitis
  • Importance of patient and caregiver education for optimal management
  • Data on new and emerging therapies and the game changers in Atopic Dermatitis
Docplexus: One of the world's largest online communities of Doctors
Pune - 411045, India
info@docplexus.co.in   |  +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

No comments:

Post a Comment